Sid Subramony

Sid Subramony is a Vice President and investment professional at Boxer Capital, where he focuses on biotechnology and healthcare investments. In this role, he conducts comprehensive due diligence on both public and private companies by evaluating scientific literature, clinical trial data, regulatory communications, and corporate financials. Beyond his primary investment responsibilities at Boxer Capital, he serves as a board member for Tyra Biosciences, guiding strategic decisions in the life sciences sector. He holds dual Doctor of Philosophy and Master of Business Administration degrees, utilizing his advanced academic training to assess complex healthcare innovations. Additionally, he has contributed to the broader investment community by serving as a mentor for research analyst externships focused on biotechnology investing. Subramony leverages his scientific expertise and financial acumen to identify and support emerging therapeutic platforms in the biotechnology industry.